Passa al contenuto
Merck

Placental vitamin D receptor expression is decreased in human idiopathic fetal growth restriction.

Journal of molecular medicine (Berlin, Germany) (2015-02-27)
T P H Nguyen, H E J Yong, T Chollangi, A J Borg, S P Brennecke, P Murthi
ABSTRACT

Fetal growth restriction (FGR) affects up to 5 % of pregnancies worldwide, and trophoblast function plays a significant role on the outcome. An epidemiological study has linked vitamin D deficiency to adverse perinatal outcomes, which include decreased birth weight. The placenta as an important source of vitamin D regulates its metabolism through the vitamin D receptor (VDR), but the mechanism by which VDR regulates trophoblast function is poorly understood. Our study aimed at determining placental VDR expression in FGR and gestation-matched control (GMC) pregnancies and identifying the actions of VDR in trophoblast differentiation and apoptosis. Placentae were collected from a well-defined cohort of idiopathic FGR and GMC pregnancies. VDR mRNA and protein expressions were determined by PCR, immunohistochemistry and immunoblotting, while functional consequences of VDR inactivation in vitro were determined on BeWo cells by determining changes in differentiation, attachment and apoptosis. Significant decreases in VDR mRNA expression (p = 0.0005) and protein expression (p = 0.0003) were observed in the FGR samples, while VDR inactivation, which showed markers for differentiation, cell attachment and apoptosis, was significantly increased. Thus, decreased placental VDR may contribute to uncontrolled premature differentiation and apoptosis of trophoblasts that are characteristics of idiopathic FGR pregnancies. Fetal growth restriction (FGR) affects up to 5 % of all pregnancies worldwide. FGR is the second highest cause of perinatal mortality and morbidity. The placenta plays a pivotal role in vitamin D metabolism during pregnancy. Vitamin D deficiency is associated with adverse pregnancy outcomes. Placental vitamin D receptor expression is decreased in FGR.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Sodio dodecil solfato, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC)
Sigma-Aldrich
Sodio cloruro, for molecular biology, DNase, RNase, and protease, none detected, ≥99% (titration)
Sigma-Aldrich
Sodio dodecil solfato, ≥99.0% (GC), dust-free pellets
Sigma-Aldrich
Sodio cloruro, 5 M in H2O, BioReagent, for molecular biology, suitable for cell culture
Sigma-Aldrich
Sodio cloruro, BioXtra, ≥99.5% (AT)
Sigma-Aldrich
Sodio cloruro, 0.9% in water, BioXtra, suitable for cell culture
Sigma-Aldrich
L-glutammina, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
Sodio dodecil solfato, BioUltra, for molecular biology, 10% in H2O
Sigma-Aldrich
Forskolina, from Coleus forskohlii, ≥98% (HPLC), powder
Sigma-Aldrich
Sodio dodecil solfato, ACS reagent, ≥99.0%
Sigma-Aldrich
Sodio cloruro, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99%
Sigma-Aldrich
Sodio dodecil solfato, ReagentPlus®, ≥98.5% (GC)
Sigma-Aldrich
L-glutammina, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Forskolina, For use in molecular biology applications
SAFC
Sodio cloruro, 5 M
Sigma-Aldrich
Sodio dodecil solfato, BioUltra, for molecular biology, 20% in H2O
Sigma-Aldrich
Sodio dodecil solfato, BioUltra, for molecular biology, ≥99.0% (GC)
SAFC
L-glutammina
Sigma-Aldrich
Sodio cloruro, meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%
Sigma-Aldrich
Sodio cloruro, BioUltra, for molecular biology, ~5 M in H2O